EDA - Risk-based PMS Plan Samples Analyzed in CADC Laboratories in 2025

Sorry, this website does not support this browser

Cookies Disclaimer

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Ok

- A+
- |
- A-
- A
15301
- English
- العربية

- English
- العربية
- A+
- |
- A-
- A

Click Here
15301

Home Page
About Us
Services
The Regulatory Reference of the Egyptian Drug Authority (EDA)
Publications ,Reports and EDA In Numbers
Media Center
Egyptian Pharmacopoeia
Awareness
Localization of Industry
- Localization of Modern Pharmaceutical Industries
Center for Continuing Professional Development (CPD)

Home Page
Publications ,Reports and EDA In Numbers
EDA in numbers
Laboratory testing activities metrics Of CA Of CADC
Laboratory testing activities metrics for the year 2025
Risk-based PMS Plan Samples Analyzed in CADC Laboratories in 2025

Laboratory testing activities metrics for the year 2025

Risk-based PMS Plan Samples Analyzed in CADC Laboratories in 2025

The Egyptian Drug Authority is a public service body with a legal personality affiliated with the Prime Minister. It is responsible for organizing, implementing, and monitoring the quality, effectiveness, and safety of pharmaceutical products and medical devices stipulated in the provisions of the law establishing the Authority.

About Us

Contact us
Jobs

Contact information

Authority headquarters: Al-Manial, Al-Agouza, Al-Haram, Al-Maadi, Al-Mansouriya-New Capital
15301
info@edaegypt.gov.eg

Social media platforms

Copy Rights @ EDA 2021